Ann: Imugene Receives FDA IND Approval for PD1-VAXX Trial in USA, page-71

It’s also worth noting that CF33 is not new science. It’s not a new frontier . Unlike Car-T therapy , Oncolyric Virus Therapy is much more advanced therapeutically

The team that worked at VLA are now working with Professor Yuman Fong to make CF33 a success.

Having met Professor Fong , I am quietly confidant that CF33 could be the biggest thing in Cancer therapy that has ever been developed.

LC has designed these trials to give us very quick signals as to efficacy. Investors and potential Licensees won’t need time wait years to know what if CF33 is effective.

CF33 can be loaded with different payloads , one possibility is Radioactive Iodine. So that’s two distinct therapies targeting the Cancer Cells.

CF33 can also be tagged so Doctors can actually watch CF33 attacking the cancers cells in real time on MRI.

That makes a very compelling case for me to be heavily invested here.